BSE Live
Oct 06, 16:01Prev. Close
12.80
Open Price
12.56
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Gennex Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 22.74 | 22.74 | 18.02 | 12.65 | 12.65 | |
Total Share Capital | 22.74 | 22.74 | 18.02 | 12.65 | 12.65 | |
Reserves and Surplus | 162.05 | 142.30 | 61.00 | 31.35 | 27.24 | |
Total Reserves and Surplus | 162.05 | 142.30 | 61.00 | 31.35 | 27.24 | |
Total Shareholders Funds | 184.80 | 170.76 | 79.02 | 44.00 | 39.89 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | |
Other Long Term Liabilities | 4.47 | 1.76 | 1.29 | 0.00 | 0.00 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 4.47 | 1.76 | 1.29 | 0.00 | 0.15 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 1.24 | 0.85 | 0.98 | 10.12 | 7.36 | |
Trade Payables | 10.84 | 14.35 | 6.49 | 7.74 | 5.94 | |
Other Current Liabilities | 16.44 | 17.17 | 7.83 | 5.71 | 5.18 | |
Short Term Provisions | 0.59 | 0.45 | 0.61 | 0.63 | 0.56 | |
Total Current Liabilities | 29.11 | 32.82 | 15.91 | 24.21 | 19.04 | |
Total Capital And Liabilities | 218.38 | 205.34 | 96.22 | 68.21 | 59.08 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 19.66 | 15.83 | 15.18 | 13.70 | 14.13 | |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 2.62 | 1.38 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 22.29 | 17.21 | 15.18 | 13.70 | 14.13 | |
Non-Current Investments | 8.25 | 8.26 | 8.26 | 7.01 | 7.01 | |
Deferred Tax Assets [Net] | 0.18 | 0.23 | 0.14 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 0.64 | 0.64 | 0.48 | 0.32 | 0.28 | |
Total Non-Current Assets | 31.36 | 26.35 | 24.06 | 21.03 | 21.42 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 24.59 | 16.07 | 14.97 | 7.74 | 5.02 | |
Trade Receivables | 11.89 | 13.57 | 8.82 | 11.31 | 8.95 | |
Cash And Cash Equivalents | 55.56 | 60.96 | 14.45 | 8.31 | 1.07 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 94.99 | 88.39 | 33.91 | 19.82 | 22.63 | |
Total Current Assets | 187.02 | 178.99 | 72.16 | 47.18 | 37.67 | |
Total Assets | 218.38 | 205.34 | 96.22 | 68.21 | 59.08 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 1.96 | 0.74 | 0.74 | 1.70 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 1.67 | 8.06 | 7.86 | 2.42 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.28 | 0.57 | 0.33 | 0.45 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | 21.11 | 25.01 | 32.14 | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | 8.26 | 7.01 | 7.01 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
11.06.2025
Gennex Labs Standalone March 2025 Net Sales at Rs 23.28 crore, up 9.14% Y-o-Y
03.06.2025
Gennex Labs Consolidated March 2025 Net Sales at Rs 40.33 crore, up 20.36% Y-o-Y
04.03.2025
Gennex Labs Consolidated December 2024 Net Sales at Rs 40.01 crore, up 108.98% Y-o-Y
28.11.2024
Gennex Labs Consolidated September 2024 Net Sales at Rs 31.55 crore, up 79.46% Y-o-Y
11.06.2025
Gennex Labs Standalone March 2025 Net Sales at Rs 23.28 crore, up 9.14% Y-o-Y
03.06.2025
Gennex Labs Consolidated March 2025 Net Sales at Rs 40.33 crore, up 20.36% Y-o-Y
04.03.2025
Gennex Labs Consolidated December 2024 Net Sales at Rs 40.01 crore, up 108.98% Y-o-Y
28.11.2024
Gennex Labs Consolidated September 2024 Net Sales at Rs 31.55 crore, up 79.46% Y-o-Y